Rituximab therapy for Wegener's granulomatosis refractory to conventional treatment

被引：0
|
作者：
Sanchez-Escuredo, A. [1 ]
Nunez, R. [2 ]
Ibernon, M. [1 ]
Martinez, E. [3 ]
Lopez, D. [4 ]
Navarro, M. [1 ]
Bonet, J. [1 ]
Ara, J. [1 ]
Romero, R. [1 ]
机构：
[1] Hosp Badalona Germans Trias & Pujol, Serv Nefrol, Barcelona 08916, Spain
[2] Hosp Badalona Germans Trias & Pujol, Med Interna Serv, Barcelona 08916, Spain
[3] Hosp Badalona Germans Trias & Pujol, Serv Inmunol, Barcelona 08916, Spain
[4] Hosp Badalona Germans Trias & Pujol, Serv Anat Patol, Barcelona 08916, Spain
来源：
NEFROLOGIA | 2011年 / 31卷 / 04期
关键词：
ANTIBODY-ASSOCIATED VASCULITIS; CYCLOPHOSPHAMIDE;
D O I：
10.3265/Nefrologia.pre2011.May.10772
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：502 / 504
页数：3
相关论文
共 50 条
  • [31] B-cell depletion with rituximab for refractory ENT Wegener's granulomatosis
    Del Pero, Marcos Martinez
    Chaudhry, Afzal
    Jones, Rachel B.
    Sivasothy, Pasupathy
    Jani, Piyush
    Jayne, David
    APMIS, 2009, 117 : 68 - 68
  • [32] REFRACTORY WEGENER'S GRANULOMATOSIS WITH A VERY GOOD RESPONSE TO RITUXIMAB (MABTHERA) AND CYCLOSPORIN A
    Klimecka, I.
    Adamczak, K.
    Kaminiarczyk-Pyzalka, D.
    Niedziela, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 193 - 193
  • [33] RITUXIMAB IN THE MANAGEMENT OF REFRACTORY NEUROLOGICAL MANIFESTATIONS OF WEGENER'S GRANULOMATOSIS: A CASE REPORT
    Lutalo, Pamela M.
    Scott, Ian C.
    Sangle, Shirish
    D'Cruz, David P.
    RHEUMATOLOGY, 2011, 50 : 45 - 46
  • [34] Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis
    Tektonidou, M. G.
    Skopouli, F. N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (02) : S103 - S103
  • [35] Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations
    Holle, Julia U.
    Dubrau, Christin
    Herlyn, Karen
    Heller, Martin
    Ambrosch, Petra
    Noelle, Bernhard
    Reinhold-Keller, Eva
    Gross, Wolfgang L.
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (03) : 327 - 333
  • [36] Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease
    Sanchez-Cano, D.
    Callejas-Rubio, J. L.
    Ortego-Centeno, N.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2008, 14 (02) : 92 - 93
  • [37] Successful treatment of refractory Wegener's granulomatosis with infliximab.
    Lamprecht, P
    Voswinkel, J
    Lilienthal, T
    Noelle, B
    Heller, M
    Gross, WI
    Gause, A
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S56 - S56
  • [38] Efficacy of etoposide treatment in patients with refractory Wegener's granulomatosis
    Rysava, R.
    Tesaf, V.
    Merta, M.
    Vankova, Z.
    Jancova, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (01) : S114 - S114
  • [39] Rituximab and Wegener's granulomatosis: Are B cells a target in vasculitis treatment?
    Sneller, MC
    ARTHRITIS AND RHEUMATISM, 2005, 52 (01): : 1 - 5
  • [40] Conventional treatment and outcome of Wegener's granulomatosis and microscopic polyangiitis
    Jayne, DRW
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2002, 69 (05) : 110 - 115
12345